Literature DB >> 12912895

Formation and remodeling of inositolphosphoceramide during differentiation of Trypanosoma cruzi from trypomastigote to amastigote.

Maria Laura Salto1, Laura E Bertello, Mauricio Vieira, Roberto Docampo, Silvia N J Moreno, Rosa M de Lederkremer.   

Abstract

Differentiation of Trypanosoma cruzi trypomastigotes to amastigotes inside myoblasts or in vitro, at low extracellular pH, in the presence of [(3)H]palmitic acid or [(3)H]inositol revealed differential labeling of inositolphosphoceramide and phosphatidylinositol, suggesting that a remodeling process takes place in both lipids. Using (3)H-labeled inositolphosphoceramide and phosphatidylinositol as substrates, we demonstrated the association of at least five enzymatic activities with the membranes of amastigotes and trypomastigotes. These included phospholipase A(1), phospholipase A(2), inositolphosphoceramide-fatty acid hydrolase, acyltransferase, and a phospholipase C releasing either ceramide or a glycerolipid from the inositolphospholipids. These enzymes may be acting in remodeling reactions leading to the anchor of mature glycoproteins or glycoinositolphospholipids and helping in the transformation of the plasma membrane, a necessary step in the differentiation of slender trypomastigotes to round amastigotes. Synthesis of inositolphosphoceramide and particularly of glycoinositolphospholipids was inhibited by aureobasidin A, a known inhibitor of fungal inositolphosphoceramide synthases. The antibiotic impaired the differentiation of trypomastigotes at acidic pH, as indicated by an increased appearance of intermediate forms and a decreased expression of the Ssp4 glycoprotein, a characteristic marker of amastigote forms. Aureobasidin A was also toxic to differentiating trypomastigotes at acidic pH but not to trypomastigotes maintained at neutral pH. Our data suggest that inositolphosphoceramide is implicated in T. cruzi differentiation and that its metabolism could provide important targets for the development of antiparasitic therapies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12912895      PMCID: PMC178363          DOI: 10.1128/EC.2.4.756-768.2003

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  36 in total

Review 1.  Recent developments in the chemotherapy of Chagas disease.

Authors:  R Docampo
Journal:  Curr Pharm Des       Date:  2001-08       Impact factor: 3.116

2.  The phosphatidylinositol-phospholipase C from Trypanosoma cruzi is active on inositolphosphoceramide.

Authors:  María Laura Salto; Tetsuya Furuya; Silvia N Moreno; Roberto Docampo; Rosa M de Lederkremer
Journal:  Mol Biochem Parasitol       Date:  2002-01       Impact factor: 1.759

3.  Isotopes incorporated in the nucleic acids of Trypanosoma mega.

Authors:  G J BONE; M STEINERT
Journal:  Nature       Date:  1956-08-11       Impact factor: 49.962

4.  Lysosomal phospholipase A1 in Trypanosoma cruzi: an enzyme with a possible role in the pathogenesis of Chagas' disease.

Authors:  M Wainszelbaum; E Isola; S Wilkowsky; J J Cannata; J Florin-Christensen; M Florin-Christensen
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

5.  Phosphatidylinositol-specific phospholipase C (PI-PLC) cleavage of GPI-anchored surface molecules of Trypanosoma cruzi triggers in vitro morphological reorganization of trypomastigotes.

Authors:  R A Mortara; L M Minelli; F Vandekerckhove; V Nussenzweig; F J Ramalho-Pinto
Journal:  J Eukaryot Microbiol       Date:  2001 Jan-Feb       Impact factor: 3.346

Review 6.  Glycoinositolphospholipids, free and as anchors of proteins, in Trypanosoma cruzi.

Authors:  R M Lederkremer; L E Bertello
Journal:  Curr Pharm Des       Date:  2001-08       Impact factor: 3.116

Review 7.  Cell biology of Trypanosoma cruzi.

Authors:  W de Souza
Journal:  Int Rev Cytol       Date:  1984

Review 8.  Gangliosides: structure, isolation, and analysis.

Authors:  R W Ledeen; R K Yu
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

9.  A novel phosphatidylinositol-phospholipase C of Trypanosoma cruzi that is lipid modified and activated during trypomastigote to amastigote differentiation.

Authors:  T Furuya; C Kashuba; R Docampo; S N Moreno
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

10.  Evidence for phospholipases from Trypanosoma cruzi active on phosphatidylinositol and inositolphosphoceramide.

Authors:  L E Bertello; M J Alves; W Colli; R M de Lederkremer
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

View more
  22 in total

1.  De novo sphingolipid synthesis is essential for viability, but not for transport of glycosylphosphatidylinositol-anchored proteins, in African trypanosomes.

Authors:  Shaheen S Sutterwala; Caleb H Creswell; Sumana Sanyal; Anant K Menon; James D Bangs
Journal:  Eukaryot Cell       Date:  2007-01-12

Review 2.  Phospholipid and sphingolipid metabolism in Leishmania.

Authors:  Kai Zhang; Stephen M Beverley
Journal:  Mol Biochem Parasitol       Date:  2009-12-23       Impact factor: 1.759

3.  Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis.

Authors:  Kai Zhang; Fong-Fu Hsu; David A Scott; Roberto Docampo; John Turk; Stephen M Beverley
Journal:  Mol Microbiol       Date:  2005-03       Impact factor: 3.501

Review 4.  Sphingolipids in parasitic protozoa.

Authors:  Kai Zhang; James D Bangs; Stephen M Beverley
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Characterization of the inositol phosphorylceramide synthase activity from Trypanosoma cruzi.

Authors:  Juliana M Figueiredo; Wagner B Dias; Lucia Mendonça-Previato; José O Previato; Norton Heise
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

6.  Molecular and functional characterization of the ceramide synthase from Trypanosoma cruzi.

Authors:  Juliana M Figueiredo; Deivid C Rodrigues; Rafael C M C Silva; Carolina M Koeller; James C Jiang; S Michal Jazwinski; José O Previato; Lucia Mendonça-Previato; Turán P Urményi; Norton Heise
Journal:  Mol Biochem Parasitol       Date:  2011-12-30       Impact factor: 1.759

7.  Phospholipid and glycolipid composition of acidocalcisomes of Trypanosoma cruzi.

Authors:  María Laura Salto; Theresa Kuhlenschmidt; Mark Kuhlenschmidt; Rosa M de Lederkremer; Roberto Docampo
Journal:  Mol Biochem Parasitol       Date:  2007-12-07       Impact factor: 1.759

8.  Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A.

Authors:  Paul A Aeed; Casey L Young; Marek M Nagiec; Ake P Elhammer
Journal:  Antimicrob Agents Chemother       Date:  2008-12-01       Impact factor: 5.191

9.  In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: antiproliferative, biochemical, and ultrastructural effects.

Authors:  Juliany Cola Fernandes Rodrigues; Juan Luis Concepcion; Carlos Rodrigues; Aura Caldera; Julio A Urbina; Wanderley de Souza
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

10.  Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.

Authors:  Wanderley de Souza; Juliany Cola Fernandes Rodrigues
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.